Christopher J Byrne (Christopher Byrne)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Venues

BMJ open gastroenterology

PloS one

BMJ open

Alimentary pharmacology & therapeutics

Edinburgh Napier University (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Edinburgh Napier University

United Kingdom

MSC

Publications

Christopher J Byrne, Paul Noel Brennan, James Carberry, James Cotton, John F Dillon
Long-term risk factors for developing Barrett's oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study. BMJ open gastroenterology 11 (1) (2024)
Marc Gurun, Paul Noel Brennan, Sava Handjiev, Aseil Khatib, Damien Leith, John F Dillon, Christopher J Byrne
Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis. PloS one 19 (4) (2024)
Christopher J Byrne, Paul Noel Brennan, James Carberry, James Cotton, John F Dillon
Long-term risk factors for developing Barrett's oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study. BMJ open gastroenterology 11 (1) (2024)
Marc Gurun, Paul Noel Brennan, Sava Handjiev, Aseil Khatib, Damien Leith, John F Dillon, Christopher J Byrne
Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis. PloS one 19 (4) (2024)
Marc Gurun, Paul Noel Brennan, Sava Handjiev, Aseil Khatib, Damien Leith, John F Dillon, Christopher J Byrne
Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis. PloS one 19 (4) (2024)
Marc Gurun, Paul Noel Brennan, Sava Handjiev, Aseil Khatib, Damien Leith, John F Dillon, Christopher J Byrne
Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis. PloS one 19 (4) (2024)
Christopher J Byrne, Paul Noel Brennan, James Carberry, James Cotton, John F Dillon
Long-term risk factors for developing Barrett's oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study. BMJ open gastroenterology 11 (1) (2024)
Christopher J Byrne, Paul Noel Brennan, James Carberry, James Cotton, John F Dillon
Long-term risk factors for developing Barrett's oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study. BMJ open gastroenterology 11 (1) (2024)
Christopher J Byrne, Amy Malaguti, Sarah Karen Inglis, John F Dillon
Mixed-methods evaluation of point-of-care hepatitis C virus RNA testing in a Scottish prison. BMJ open 13 (4) (2023)
Amy Malaguti, Christopher J Byrne, Fabio Sani, Kevin Power, Ann Eriksen, John F Dillon
Drug network identification predicts injecting risk behavior among people who inject drugs on hepatitis C virus treatment in Tayside, Scotland. Behavioral medicine (Washington, D.C.) (2022)
Christopher J Byrne, Andrew Radley, Sarah K Inglis, Lewis Beer, Nicki Palmer, Minh Duc Pham, Kate Allardice, Huan Wang, Emma Robinson, Monika Hermansson, Dimitri Semizarov, Brendan Healy, Joseph S Doyle, John F Dillon
Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: an international randomised controlled trial. Alimentary pharmacology & therapeutics 55 (12) (2022)
Christopher J Byrne, Lewis Beer, Sarah K Inglis, Emma Robinson, Andrew Radley, David J Goldberg, Matthew Hickman, Sharon J Hutchinson, John F Dillon
Real-world outcomes of rapid regional hepatitis c virus treatment scale-up among people who inject drugs in Tayside, Scotland. Alimentary pharmacology & therapeutics (2021)
Christopher J Byrne, Andrew Radley, Sarah Karen Inglis, Lewis J Z Beer, Nicki Palmer, Minh Duc Pham, Brendan Healy, Joseph S Doyle, Peter Donnan, John F Dillon
Reaching mEthadone users Attending Community pHarmacies with HCV: an international cluster randomised controlled trial protocol (REACH HCV). BMJ open 10 (8) (2020)
Christopher J Byrne, Emma Robinson, Nikolas Rae, John F Dillon
Toward microelimination of hepatitis C and HIV coinfection in NHS Tayside, Scotland: Real-world outcomes. Health science reports 3 (4) (2020)

Christopher J Byrne.css-eqlu8i{font-size:small;padding-left:4px;} (Christopher Byrne)

Publication Activity (10 Years)

Top Topics

Top Venues

Christopher J Byrne (Christopher Byrne)